Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples

Sereina Herzog, Jessie De Bie, Steven Abrams, Ine Wouters, Esra Ekinci, Lisbeth Patteet, Astrid Coppens, Sandy De Spiegeleer, Philippe Beutels, Pierre Van Damme, Niel Hens, Heidi Theeten
doi: https://doi.org/10.1101/2020.06.08.20125179

Article usage

Article usage: June 2020 to December 2023

AbstractFullPdf
Jun 202019500915
Jul 20209950397
Aug 20208190437
Sep 20204920274
Oct 202010983479
Nov 202080711320
Dec 202055441194
Jan 202150278148
Feb 202165058110
Mar 202161159167
Apr 20211073117206
May 202145554124
Jun 2021710439141
Jul 202162371109
Aug 20214985885
Sep 202142680139
Oct 20212773299
Nov 20213022189
Dec 20212426683
Jan 20222121742
Feb 2022189835
Mar 20221541337
Apr 20221121640
May 2022146752
Jun 2022938202
Jul 20221049162
Aug 20221061621
Sep 2022123743
Oct 20221441026
Nov 202284926
Dec 2022681023
Jan 202393522
Feb 2023822025
Mar 2023116811
Apr 202386632
May 202368429
Jun 202327612
Jul 202322427
Aug 2023661525
Sep 20231311218
Oct 2023218824
Nov 2023412627
Dec 2023403
Back to top
Posted October 01, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples
Sereina Herzog, Jessie De Bie, Steven Abrams, Ine Wouters, Esra Ekinci, Lisbeth Patteet, Astrid Coppens, Sandy De Spiegeleer, Philippe Beutels, Pierre Van Damme, Niel Hens, Heidi Theeten
medRxiv 2020.06.08.20125179; doi: https://doi.org/10.1101/2020.06.08.20125179
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area